Side Effects of ALK+ Lung Cancer Treatment

Upal Basu Roy, PhD, MPH, LUNGevity's Executive Director of Research, speaks with Justin Gainor, MD Director, Center for Thoracic Cancers Director of Targeted Immunotherapy, to discuss ALK-positive lung cancer and what side effects patients may anticipate based on their treatment options.